Association between abnormal IMDC laboratory criteria after surgery and cancer-specific and overall survival in non-metastatic renal cell carcinoma: Potential biomarkers for adjuvant therapy patient selection.
Caio Vinícius Suartz(NOSM University), Frédéric Pouliot(Université Laval), Simon Tanguay(McGill University Health Centre), Naveen S. Basappa, Rodney H. Breau(University of Ottawa), Aly‐Khan A. Lalani(Juravinski Cancer Centre), Bimal Bhindi, Georg A. Bjarnason(Sunnybrook Health Science Centre), Lori Wood(Dalhousie University), Kaleem Atchia(Université Laval), Ranjeeta Mallick(University of Ottawa), Daniel Yick Chin Heng(University of Calgary), Camilla Tajzler
Cited by 0
Related Papers
Prevalence, Risk Factors, and Outcomes of Delirium in Mechanically Ventilated Adults*
|Critical Care Medicine|2014|341
Exosomes Induce Fibroblast Differentiation into Cancer-Associated Fibroblasts through TGFβ Signaling
|Molecular Cancer Research|2018|322
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268
Change in neutrophil-to-lymphocyte ratio (NLR) in response to immune checkpoint blockade for metastatic renal cell carcinoma
|Journal for ImmunoTherapy of Cancer|2018|267